Health Catalyst (HCAT) Projected to Post Quarterly Earnings on Thursday

Health Catalyst (NASDAQ:HCAT) is expected to be releasing its Q2 2025 earnings data after the market closes on Thursday, August 7th. Analysts expect Health Catalyst to post earnings of $0.05 per share and revenue of $80.59 million for the quarter.

Health Catalyst Trading Down 6.1%

Shares of NASDAQ HCAT opened at $3.68 on Thursday. Health Catalyst has a fifty-two week low of $3.49 and a fifty-two week high of $9.24. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.24 and a current ratio of 1.24. The company has a market cap of $256.13 million, a price-to-earnings ratio of -3.20 and a beta of 1.51. The business’s 50 day moving average price is $3.86 and its 200-day moving average price is $4.37.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on HCAT shares. Evercore ISI reduced their target price on Health Catalyst from $5.00 to $4.00 and set an “in-line” rating on the stock in a research note on Wednesday, July 9th. Canaccord Genuity Group cut their price target on shares of Health Catalyst from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday, May 8th. Citigroup decreased their price objective on shares of Health Catalyst from $7.00 to $6.50 and set a “buy” rating for the company in a report on Friday, April 25th. KeyCorp lowered their price objective on shares of Health Catalyst from $7.00 to $5.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. Finally, Stifel Nicolaus raised their target price on shares of Health Catalyst from $5.00 to $5.50 and gave the stock a “hold” rating in a research report on Thursday, May 8th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $8.00.

Institutional Investors Weigh In On Health Catalyst

Large investors have recently modified their holdings of the business. AQR Capital Management LLC boosted its stake in shares of Health Catalyst by 816.8% during the first quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock valued at $763,000 after purchasing an additional 149,981 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Health Catalyst by 7.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company’s stock worth $163,000 after buying an additional 2,624 shares in the last quarter. Finally, Focus Partners Wealth purchased a new stake in Health Catalyst during the first quarter worth $46,000. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.